Sanja Erceg

8PUBLICATIONS
34CO-AUTHORS
Medical biochemistry - lipidsMajor global burdens of diseaseMetabolic medicineProfessional writing and journalism practicePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 24, 2025
Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes.

Sanja Erceg, Ana Ninić, Jelena Kotur-Stevuljević

|Sep 27, 2025
Association Between Redox and Inflammatory Biomarkers with the Presence and Severity of Obstructive Sleep Apnea.

Ana Ninić, Branislava Rajkov, Jelena Kotur-Stevuljević

|Aug 14, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Characterized by Enhanced Endogenous Cholesterol Synthesis and Impaired Synthesis/Absorption Balance.

Irena Frankovic, Aleksandra Zeljkovic, Ivana Djuricic

|Jun 26, 2025
Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study.

Miloš Mitrović, Verica Stanković Popović, Sanja Erceg

|Mar 27, 2025
Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes.

Sanja Erceg, Jelena Munjas, Miron Sopić

|Aug 29, 2024
Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma.

Irena Frankovic, Ivana Djuricic, Ana Ninic

Pageof 2

Frequent Collaborators

5 joint publications

Ana Ninic

4 joint publications

Milos Mitrovic

3 joint publications

Jelena Kotur-Stevuljevic

3 joint publications

Jelena Munjas